financetom
Business
financetom
/
Business
/
Why Infrastructure Company Ferrovial Shares Are Falling Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Infrastructure Company Ferrovial Shares Are Falling Today
Jun 12, 2024 9:29 AM

Ferrovial SE ( FER ) shares are trading lower after the company divested a 5% stake in Indian firm IRB Infrastructure Developers (IRB) through its subsidiary Cintra.

The transaction amounted to EUR214 million, based on a EUR/INR exchange rate of 89.72.

The sale was conducted as a block deal or placement of 301.9 million shares with institutional investors on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) at an average price of INR63.60.

The estimated pre-tax capital gain from this transaction amounts to EUR130 million.

This move aligns with Ferrovial’s strategy in India, complementing its recent acquisition of a 24% stake in IRB Infrastructure Trust and capitalizing on the significant long-term growth prospects in the Indian market.

This sale will bolster the liquidity of IRB Infrastructure Developers shares. Ferrovial will retain its position as the second-largest shareholder, holding a 19.9% stake, and maintain representation on the Board of Directors.

Ferrovial concluded the first quarter with high liquidity levels of €4.9 billion and consolidated net debt of €(667) million.

Investors can gain exposure to the stock via IShares Inc IShares MSCI Spain ETF and, ClearBridge Sustainable Infrastructure ETF ( INFR ) .

Price Action: FER shares are down 3.31% at $40.02 at the last check Wednesday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Performance Food Fiscal Q1 Adjusted Earnings, Sales Rise; Updates Fiscal 2026 Revenue Guidance
Performance Food Fiscal Q1 Adjusted Earnings, Sales Rise; Updates Fiscal 2026 Revenue Guidance
Nov 5, 2025
07:44 AM EST, 11/05/2025 (MT Newswires) -- Performance Food Group ( PFGC ) reported fiscal Q1 adjusted earnings Wednesday of $1.18 per diluted share, up from $1.16 a year earlier. Analysts polled by FactSet expected $1.21. Net sales for the quarter ended Sept. 27 were $17.08 billion, compared with $15.42 billion a year earlier. Analysts surveyed by FactSet expected $16.88...
Charles River Laboratories Fiscal Q3 Non-GAAP Earnings, Revenue Drop; Fiscal 2025 Guidance Updated
Charles River Laboratories Fiscal Q3 Non-GAAP Earnings, Revenue Drop; Fiscal 2025 Guidance Updated
Nov 5, 2025
07:44 AM EST, 11/05/2025 (MT Newswires) -- Charles River Laboratories International ( CRL ) reported fiscal Q3 non-GAAP earnings Wednesday of $2.43 per diluted share, down from $2.59 a year earlier. Analysts polled by FactSet expected $2.34. Total revenue for the quarter ended Sept. 27 was $1 billion, down from $1.01 billion a year earlier. Analysts surveyed by FactSet expected...
Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs
Ozempic Maker Novo Nordisk Trims Growth Outlook For Obesity Drugs
Nov 5, 2025
Novo Nordisk A/S ( NVO ) on Wednesday reported third-quarter 2025 sales of roughly $11.75 billion (74.98 billion Danish kroner), slightly below the consensus of $11.88 billion. Sales increased by 5% in Danish kroner and 11% at constant currency. GLP-1 diabetes sales increased by 11% to 36.74 billion Danish kroner, and Obesity care sales increased by 18% to 21.11 billion...
Research Alert: Tech: Q1 Fy 26 Sales Performance Disappoint, Completes The Exosome Divestiture
Research Alert: Tech: Q1 Fy 26 Sales Performance Disappoint, Completes The Exosome Divestiture
Nov 5, 2025
07:45 AM EST, 11/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Bio-Techne ( TECH ) reported Q1 FY 26 (Jun.) adjusted EPS of $0.42 (flat Y/Y), in line with consensus, while revenue declined 1% Y/Y to $286.6M, below consensus. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved